Bio-Techne Corp. stock underperforms Thursday when compared to competitors
This was the stock's second consecutive day of losses.
Bio-Techne Co. (NASDAQ:TECH) Receives $82.00 Average Target Price from Brokerages
Shares of Bio-Techne Co. (NASDAQ:TECH – Get Free Report) have received a consensus recommendation of “Moderate Buy” from the ...
Bio-Techne Corp. stock outperforms competitors on strong trading day
Bio-Techne Corp. closed 7.97% below its 52-week high of $85.57, which the company reached on May 15th.
ScaleReady Announces a G-Rex® Grant has been awarded to BrainChild Bio
ScaleReady, in collaboration with Wilson Wolf Manufacturing, Bio-Techne Corporation and CellReady, today announced that ...
Barchart on MSN4d
Bio-Techne Earnings Preview: What to Expect
Minneapolis, Minnesota-based Bio-Techne Corporation (TECH) develops, manufactures, and sells life science reagents, ...
bovnews5d
Why Is BIO-TECHNE Corp (TECH) Stock Surpassing 2.50% from Its 50-Day SMA?
Citigroup has recently reduced BIO-TECHNE Corp (TECH) stock to Neutral rating, as announced on May 22, 2024, according to Finviz. Earlier, on February 8, 2024, Scotiabank had initiated the stock to ...